Goldman Sachs’s Inogen INGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.59M | Sell |
580,100
-9,173
| -2% | -$56.6K | ﹤0.01% | 4013 |
|
|
2025
Q4 | $3.96M | Buy |
589,273
+160,960
| +38% | +$1.21M | ﹤0.01% | 3956 |
|
|
2025
Q3 | $3.5M | Buy |
428,313
+174,948
| +69% | +$1.31M | ﹤0.01% | 3974 |
|
|
2025
Q2 | $1.78M | Sell |
253,365
-30,815
| -11% | -$207K | ﹤0.01% | 4266 |
|
|
2025
Q1 | $2.03M | Buy |
284,180
+41,002
| +17% | +$387K | ﹤0.01% | 4150 |
|
|
2024
Q4 | $2.23M | Buy |
243,178
+77,066
| +46% | +$721K | ﹤0.01% | 4181 |
|
|
2024
Q3 | $1.61M | Sell |
166,112
-10,980
| -6% | -$115K | ﹤0.01% | 4336 |
|
|
2024
Q2 | $1.44M | Buy |
177,092
+20,537
| +13% | +$159K | ﹤0.01% | 4190 |
|
|
2024
Q1 | $1.26M | Buy |
156,555
+2,085
| +1% | +$14.8K | ﹤0.01% | 4187 |
|
|
2023
Q4 | $848K | Buy |
154,470
+20,042
| +15% | +$106K | ﹤0.01% | 4469 |
|
|
2023
Q3 | $702K | Sell |
134,428
-13,915
| -9% | -$98.9K | ﹤0.01% | 4475 |
|
|
2023
Q2 | $1.71M | Buy |
148,343
+11,913
| +9% | +$140K | ﹤0.01% | 3982 |
|
|
2023
Q1 | $1.7M | Buy |
136,430
+104,086
| +322% | +$1.99M | ﹤0.01% | 3983 |
|
|
2022
Q4 | $638K | Buy |
32,344
+2,348
| +8% | +$50.6K | ﹤0.01% | 4718 |
|
|
2022
Q3 | $728K | Sell |
29,996
-15,565
| -34% | -$430K | ﹤0.01% | 4725 |
|
|
2022
Q2 | $1.1M | Buy |
45,561
+22,844
| +101% | +$607K | ﹤0.01% | 4537 |
|
|
2022
Q1 | $736K | Sell |
22,717
-45,241
| -67% | -$1.42M | ﹤0.01% | 5066 |
|
|
2021
Q4 | $2.31M | Sell |
67,958
-39,780
| -37% | -$1.45M | ﹤0.01% | 4134 |
|
|
2021
Q3 | $4.64M | Buy |
107,738
+57,491
| +114% | +$3.53M | ﹤0.01% | 3430 |
|
|
2021
Q2 | $3.27M | Buy |
50,247
+976
| +2% | +$61.8K | ﹤0.01% | 3739 |
|
|
2021
Q1 | $2.59M | Sell |
49,271
-101,824
| -67% | -$5.08M | ﹤0.01% | 3736 |
|
|
2020
Q4 | $6.75M | Sell |
151,095
-188,447
| -56% | -$6.51M | ﹤0.01% | 2777 |
|
|
2020
Q3 | $9.85M | Sell |
339,542
-29,844
| -8% | -$938K | ﹤0.01% | 2339 |
|
|
2020
Q2 | $13.1M | Buy |
369,386
+24,686
| +7% | +$1.04M | ﹤0.01% | 2048 |
|
|
2020
Q1 | $17.8M | Buy |
344,700
+219,010
| +174% | +$10.5M | 0.01% | 1602 |
|
|
2019
Q4 | $8.59M | Sell |
125,690
-42,697
| -25% | -$2.68M | ﹤0.01% | 2543 |
|
|
2019
Q3 | $8.07M | Buy |
168,387
+25,155
| +18% | +$1.31M | ﹤0.01% | 2486 |
|
|
2019
Q2 | $9.56M | Sell |
143,232
-32,985
| -19% | -$2.51M | ﹤0.01% | 2389 |
|
|
2019
Q1 | $16.8M | Sell |
176,217
-14,781
| -8% | -$1.84M | 0.01% | 2020 |
|
|
2018
Q4 | $23.7M | Sell |
190,998
-17,554
| -8% | -$2.89M | 0.01% | 1673 |
|
|
2018
Q3 | $50.9M | Buy |
208,552
+34,715
| +20% | +$8.03M | 0.01% | 1211 |
|
|
2018
Q2 | $32.4M | Buy |
173,837
+42,029
| +32% | +$6.99M | 0.01% | 1544 |
|
|
2018
Q1 | $16.2M | Buy |
131,808
+48,490
| +58% | +$5.92M | ﹤0.01% | 2000 |
|
|
2017
Q4 | $9.92M | Sell |
83,318
-43,762
| -34% | -$4.82M | ﹤0.01% | 2457 |
|
|
2017
Q3 | $12.1M | Sell |
127,080
-963
| -0.8% | -$92.8K | ﹤0.01% | 2412 |
|
|
2017
Q2 | $12.2M | Buy |
128,043
+1,291
| +1% | +$110K | ﹤0.01% | 2343 |
|
|
2017
Q1 | $9.83M | Buy |
126,752
+78,223
| +161% | +$5.42M | ﹤0.01% | 2426 |
|
|
2016
Q4 | $3.26M | Sell |
48,529
-128,389
| -73% | -$7.92M | ﹤0.01% | 3418 |
|
|
2016
Q3 | $10.6M | Buy |
176,918
+163,473
| +1,216% | +$9.11M | ﹤0.01% | 2404 |
|
|
2016
Q2 | $674K | Sell |
13,445
-63,853
| -83% | -$3.04M | ﹤0.01% | 4572 |
|
|
2016
Q1 | $3.48M | Buy |
77,298
+26,833
| +53% | +$956K | ﹤0.01% | 3003 |
|
|
2015
Q4 | $2.02M | Buy |
50,465
+36,816
| +270% | +$1.56M | ﹤0.01% | 3616 |
|
|
2015
Q3 | $663K | Buy |
+13,649
| New | +$648K | ﹤0.01% | 4874 |
|
|
2014
Q3 | – | Sell |
-13,216
| Closed | -$298K | – | 7177 |
|
|
2014
Q2 | $298K | Buy |
+13,216
| New | +$219K | ﹤0.01% | 5840 |
|
Other funds holding INGN
AC
VCM
DCM
Goldman Sachs's INGN Position: Q1 2026 in Review
Goldman Sachs reduced its Inogen (INGN) stake by 1.6% in Q1 2026, selling an estimated $56.6K and leaving 580,100 shares worth $3.59M. The position accounts for ﹤0.01% of the portfolio, ranked #4013.
Goldman Sachs first reported a position in INGN in Q2 2014 and has held it in 44 quarters since. The position peaked at $50.9M in Q3 2018. 126 funds tracked by Wall St. Rank hold INGN as of Q1 2026.
- Goldman Sachs held 580,100 shares of Inogen worth $3.59M as of Q1 2026.
- Goldman Sachs sold 9,173 Inogen shares in Q1 2026, an estimated $56.6K.
- Inogen made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #4013 holding.
- Goldman Sachs first reported a position in Inogen in Q2 2014 and has held it in 44 quarters since.
- Goldman Sachs's Inogen position peaked at $50.9M in Q3 2018.
- 126 funds tracked by Wall St. Rank held Inogen as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.